In plasma, CD9 EV levels have been shown to be elevated in prostate cancer patient plasma samples relative to healthy controls.53 Expression analysis using multiple breast and prostate cancer cell lines found CD9 to be enriched in all cell line EV preparations.54 Interestingly, while CD9 was abundant in all EV preparations, the cell line expression of CD9 varied. Here, CD9 is linked to prostate cancer.